ABC30 Fresno reports on newly published research pointing to a possible fertility benefit. The link is a suggestion from one study, not a confirmed effect.
Recap by typeshit. Post by ABC30 Fresno on X.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Healio
Edinburgh researchers say known risk factors account for no more than half the drop in heart disease, and Helen Colhoun calls it a cardiovascular drug.
Mean weight loss was 1.5% to 3.2% at day 29. The cash-strapped biotech says the drug is easier on the gut and wants a partner to run phase 2.
Loading…